SI-Bone expands FY25 revenue view to $193.5M-$197.5M from $193.5M-$195.5M

Consensus $194.26M. Sees FY25 gross margin 78%. Sees FY25 operating expenses up 10%. The company said, “The updated guidance implies year-over-year growth of ~16% to ~18%. SI-BONE (SIBN) estimates full year 2025 gross margin to be 78%, and does not expect a material impact to gross margins from the recently announced tariffs. SI-Bone anticipates operating expenses to grow at ~10% at the mid-point of the revenue guidance and expects to deliver positive adjusted EBITDA for the full year 2025.”